Page 47 - TD-2-1

Tumor Discovery Breast cancer optical differentiation

Conflict of interest 5. Ferlay J, Soerjomataram I, Dikshit R, et al., 2015, Cancer
incidence and mortality worldwide: Sources, methods and
The authors declare no conflict of interest. major patterns in GLOBOCAN 2012. Int J Cancer, 136(5):
E359–E386.
Author contributions
https://doi/org/10.1002/ijc.29210
Conceptualization: Mohamed Hisham Aref, Ibrahim H.
Aboughaleb, Yasser H. El-Sharkawy 6. Mody GN, Nduaguba A, Ntirenganya F, et al., 2013,
Characteristics and presentation of patients with breast
Investigation: Mohamed Hisham Aref, Ibrahim H. cancer in Rwanda. Am J Surg, 205(4): 409–413.
Aboughaleb
Resources: Abdallah Abdelkader Hussein, Ayman https://doi.org/10.1016/j.amjsurg.2013.01.002
Mohammed Farag, Sara Abd El-Ghaffar 7. Faust O, Acharya UR, Meiburger KM, et al., 2018,
Supervision: Ayman Mohammed Farag, Sara Abd Comparative assessment of texture features for the
El-Ghaffar, Yasser H. El-Sharkawy identification of cancer in ultrasound images: A review.
Writing – original draft: Mohamed Hisham Aref, Ibrahim Biocybern Biomed Eng, 38(2): 275–296.
H. Aboughaleb 8. Etehadtavakol M, Ng EY, 2013, Breast thermography as
Writing – review & editing: Yasser H. El-Sharkawy a potential non-contact method in the early detection of
cancer: A review. J Mech Med Biol, 13(2): 1330001.
Ethics approval and consent to participate
9. Nofiele JT, Czarnota GJ, Cheng HL, 2014, Noninvasive
No experimental investigation was performed on any manganese-enhanced magnetic resonance imaging for early
individuals within this study and all patients read and detection of breast cancer metastatic potential. Mol Imaging,
signed two copies of a consent form before the beginning 13(1): 1–10.
of data collection. https://doi.org/10.2310/7290.2013.00071

Consent for publication 10. Gøtzsche PC, Jørgensen KJ, 2013, Screening for breast
cancer with mammography. Cochrane Database Syst Rev,
All the authors declare that all the participated patients had 2013(6): CD001877.
been well informed about the investigation. All patients https://doi.org/10.1002/14651858.CD001877.pub5
read and signed two copies of a consent form before the
beginning of data collection, patient data had been coded 11. Brem RF, Lenihan MJ, Lieberman J, et al., 2015, Screening
breast ultrasound: Past, present, and future. Am J Roentgenol,
and summarized in Table S2 in Supplementary file.
204(2): 234–240.
Availability of data https://doi.org/10.2214/AJR.13.12072
The authors stated and declare that all the datasets used 12. Hambly NM, Liberman L, Dershaw DD, et al., 2011,
and/or analyzed during the current study are available Background parenchymal enhancement on baseline
from the corresponding author on reasonable request. screening breast MRI: Impact on biopsy rate and short-
interval follow-up. Am J Roentgenol, 196(1): 218–224.
References https://doi.org/10.2214/AJR.10.4550
1. Ferlay J, Colombet M, Soerjomataram I, et al., 2021, Cancer 13. Mehnati P, Tirtash MJ, 2015, Comparative efficacy of four
statistics for the year 2020: An overview. Int J Cancer, 149(4): imaging instruments for breast cancer screening. Asian Pac
778–789. J Cancer Prev, 16(15): 6177–6186.
https://doi.org/10.1002/ijc.33588 https://doi.org/10.7314/apjcp.2015.16.15.6177
2. Sung H, Ferlay J, Siegel RL, et al., 2021, Global cancer 14. Gutierrez RM, Cerquera EA, Mañana G, 2012, MPGD for
statistics 2020: GLOBOCAN estimates of incidence and breast cancer prevention: A high resolution and low dose
mortality worldwide for 36 cancers in 185 countries. CA radiation medical imaging. J Instrum, 7(7): C07007.
Cancer J Clin, 71(3): 209–249.
https://doi.org/10.1088/1748-0221/7/07/C07007
https://doi.org/10.3322/caac.21660
15. Wang L, 2017, Early diagnosis of breast cancer. Sensors
3. World Health Organization, 2021, World Health Statistics (Basel), 17(7): 1572.
2021. Geneva: World Health Organization.
https://doi.org/10.3390/s17071572
4. Fitzmaurice C, Dicker D, Pain A, et al., 2015, The global 16. Breastcancer.org (2006). Your Guide to the Breast Cancer
burden of cancer 2013. JAMA Oncol, 1(4): 505–527.
Pathology Report. Available from: https://www.breastcancer.
https://doi.org/10.1001/jamaoncol.2015.0735 org [Last accessed on 2022 Nov 15].

Volume 2 Issue 1 (2023) 12 https://doi.org/10.36922/td.258